Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

1.545 +0.005 (+0.32%)
Delayed Quote Updated: 9:38 AM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 333,810
Open 1.510
Bid (Size) 1.540 (1,000)
Ask (Size) 1.550 (1,500)
Prev. Close 1.540
Today's Range 1.498 - 1.545
52wk Range 1.390 - 4.230
Shares Outstanding 31,355,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences
From Cabaletta Bio
Via GlobeNewswire

Performance

52-Week Range 63.5% below 52-week high
1.545
1.3952W Low 4.2352W High
1 Week 5.5% below 1-week high
1.391W Low 1.641W High

Cabaletta Bio, Inc. - Common Stock (CABA) traded between $1.39 and $4.23 over the past 52 weeks and last traded at $1.54, 63.5% below its 52-week high. Over the past week it ranged between $1.39 and $1.64.

Past 12 Months
-0.3%
-37.2%
-43.8%
-51.3%
-30.1%
-43.6%
1W -$0.01
1M -$0.92
3M -$1.21
6M -$1.62
YTD -$0.67
1Y -$1.20

CABA was -43.6% over the past year, -51.3% over six months, -30.1% year to date, -0.3% in the last week.

12 Months vs Market
CABA
-43.6%
DIA
+12.2%
SPY
+14.2%
QQQ
+16.7%
IWM
+11.7%

Over the past 12 months CABA returned -43.6% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +16.7% and IWM (Russell 2000) +11.7%.

Volume & Liquidity 0.07× 3-mo avg
Today 333,810 3-mo avg 4.9M
1W
4.9M
1M
5.3M
3M
4.9M
6M
4.9M
YTD
4.2M
1Y
4.0M

CABA most recently traded 333,810 shares against a 3-month average daily volume of 4.9M.

More News

Read More
News headline image
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
From Cabaletta Bio
Via GlobeNewswire
Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock? ↗
Via Stocktwits
News headline image
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
From Cabaletta Bio
Via GlobeNewswire
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
From Cabaletta Bio
Via GlobeNewswire
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
News headline image
Cabaletta Bio Announces 2026 Strategic Priorities
From Cabaletta Bio
Via GlobeNewswire
News headline image
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
From Cellares
Via Business Wire
News headline image
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗
Via Benzinga
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
From Cabaletta Bio
Via GlobeNewswire
News headline image
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
From Cabaletta Bio
Via GlobeNewswire

Frequently Asked Questions

Is Cabaletta Bio, Inc. - Common Stock publicly traded?
Yes, Cabaletta Bio, Inc. - Common Stock is publicly traded.
What exchange does Cabaletta Bio, Inc. - Common Stock trade on?
Cabaletta Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cabaletta Bio, Inc. - Common Stock?
The ticker symbol for Cabaletta Bio, Inc. - Common Stock is CABA on the Nasdaq Stock Market
What is the current price of Cabaletta Bio, Inc. - Common Stock?
The current price of Cabaletta Bio, Inc. - Common Stock is 1.545
When was Cabaletta Bio, Inc. - Common Stock last traded?
The last trade of Cabaletta Bio, Inc. - Common Stock was at 10/22/26 09:38 AM ET
What is the market capitalization of Cabaletta Bio, Inc. - Common Stock?
The market capitalization of Cabaletta Bio, Inc. - Common Stock is 48.44M
How many shares of Cabaletta Bio, Inc. - Common Stock are outstanding?
Cabaletta Bio, Inc. - Common Stock has 48M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.